BACKGROUND: Recently, a new genetic factor within the interferon regulatory factor 5 (IRF5) gene was demonstrated for systemic lupus erythematosus (SLE) through linkage and association: the rs2004640-T allele. IRF5 is involved in the production of rheumatoid arthritis (RA) cytokines, and SLE already shares with RA one genetic factor within the tyrosine phosphatase PTPN22 gene. AIM: To test the hypothesis that the SLE IRF5 genetic factor could also be shared with RA. PATIENTS AND METHODS: 100 French Caucasian trio families with RA were genotyped and analysed with the transmission disequilibrium test, the frequency comparison of the transmitted and untransmitted alleles, and the genotype relative risk. 97% power was available to detect at least a trend in favour of a factor similar to that reported for SLE. RESULTS: The analysis showed the absence of linkage and association globally and in "autoimmune" RA subsets, with a weak non-significant trend against the IRF5 rs20046470-T allele. Given the robustness of familial-based analysis, this slight negative trend provided strong evidence against even a weaker factor than that reported for SLE. CONCLUSION: Our results exclude the IRF5 rs2004640-T allele as a major genetic factor for RA in this French Caucasian population.
BACKGROUND: Recently, a new genetic factor within the interferon regulatory factor 5 (IRF5) gene was demonstrated for systemic lupus erythematosus (SLE) through linkage and association: the rs2004640-T allele. IRF5 is involved in the production of rheumatoid arthritis (RA) cytokines, and SLE already shares with RA one genetic factor within the tyrosine phosphatase PTPN22 gene. AIM: To test the hypothesis that the SLEIRF5 genetic factor could also be shared with RA. PATIENTS AND METHODS: 100 French Caucasian trio families with RA were genotyped and analysed with the transmission disequilibrium test, the frequency comparison of the transmitted and untransmitted alleles, and the genotype relative risk. 97% power was available to detect at least a trend in favour of a factor similar to that reported for SLE. RESULTS: The analysis showed the absence of linkage and association globally and in "autoimmune" RA subsets, with a weak non-significant trend against the IRF5rs20046470-T allele. Given the robustness of familial-based analysis, this slight negative trend provided strong evidence against even a weaker factor than that reported for SLE. CONCLUSION: Our results exclude the IRF5rs2004640-T allele as a major genetic factor for RA in this French Caucasian population.
Authors: A Balsa; P Barrera; R Westhovens; H Alves; K Maenaut; D Pascual-Salcedo; F Cornélis; T Bardin; L Riente; T R Radstake; G de Almeida; V Lepage; C Stravopoulos; M Spaepen; A Lopes-Vaz; D Charron; M Martinez; J F Prudhomme; P Migliorini; P Fritz Journal: Ann Rheum Dis Date: 2001-06 Impact factor: 19.103
Authors: Donato Alarcón-Segovia; Marta E Alarcón-Riquelme; Mario H Cardiel; Francisco Caeiro; Loreto Massardo; Antonio R Villa; Bernardo A Pons-Estel Journal: Arthritis Rheum Date: 2005-04
Authors: Snaevar Sigurdsson; Gunnel Nordmark; Harald H H Göring; Katarina Lindroos; Ann-Christin Wiman; Gunnar Sturfelt; Andreas Jönsen; Solbritt Rantapää-Dahlqvist; Bozena Möller; Juha Kere; Sari Koskenmies; Elisabeth Widén; Maija-Leena Eloranta; Heikki Julkunen; Helga Kristjansdottir; Kristjan Steinsson; Gunnar Alm; Lars Rönnblom; Ann-Christine Syvänen Journal: Am J Hum Genet Date: 2005-01-18 Impact factor: 11.025
Authors: F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra Journal: Arthritis Rheum Date: 1988-03
Authors: F Cornélis; S Fauré; M Martinez; J F Prud'homme; P Fritz; C Dib; H Alves; P Barrera; N de Vries; A Balsa; D Pascual-Salcedo; K Maenaut; R Westhovens; P Migliorini; T H Tran; A Delaye; N Prince; C Lefevre; G Thomas; M Poirier; S Soubigou; O Alibert; S Lasbleiz; S Fouix; C Bouchier; F Lioté; M N Loste; V Lepage; D Charron; G Gyapay; A Lopes-Vaz; D Kuntz; T Bardin; J Weissenbach Journal: Proc Natl Acad Sci U S A Date: 1998-09-01 Impact factor: 11.205
Authors: José Osorio Y Fortéa; Hulya Bukulmez; Elisabeth Petit-Teixeira; Laétitia Michou; Céline Pierlot; Séverine Cailleau-Moindrault; Isabelle Lemaire; Sandra Lasbleiz; Olivier Alibert; Patrick Quillet; Thomas Bardin; Bernard Prum; Jane M Olson; François Cornélis Journal: Arthritis Rheum Date: 2004-09
Authors: J Wipff; Y Allanore; A Kahan; O Meyer; L Mouthon; L Guillevin; C Pierlot; E Glikmans; T Bardin; C Boileau; F Cornélis; P Dieudé Journal: Ann Rheum Dis Date: 2006-02-07 Impact factor: 19.103
Authors: Philippe Dieudé; Sophie Garnier; Laëtitia Michou; Elisabeth Petit-Teixeira; Elodie Glikmans; Céline Pierlot; Sandra Lasbleiz; Thomas Bardin; Bernard Prum; François Cornélis Journal: Arthritis Res Ther Date: 2005-08-25 Impact factor: 5.156
Authors: Donna L Thibault Flesher; Xin Sun; Timothy W Behrens; Robert R Graham; Lindsey A Criswell Journal: Expert Rev Clin Immunol Date: 2010-05 Impact factor: 4.473
Authors: Vitor Hugo Teixeira; Celine Pierlot; Paola Migliorini; Alejandro Balsa; René Westhovens; Pilar Barrera; Helena Alves; Carlos Vaz; Manuela Fernandes; Dora Pascual-Salcedo; Stefano Bombardieri; Jan Dequeker; Timothy R Radstake; Piet Van Riel; Leo van de Putte; Antonio Lopes-Vaz; Thomas Bardin; Bernard Prum; François Cornélis; Elisabeth Petit-Teixeira Journal: Arthritis Res Ther Date: 2009-03-20 Impact factor: 5.156
Authors: Holger Kirsten; Jana Burkhardt; Helene Hantmann; Nico Hunzelmann; Peter Vaith; Peter Ahnert; Inga Melchers Journal: Arthritis Res Ther Date: 2009-03-26 Impact factor: 5.156